# Fresenius Kabi Oncology Limited, Baddi, India – FDA Inspections

Source: https://www.keypedia.com/companies/fresenius-kabi-oncology-limited/d092c98c-aa35-490f-97c4-3ed02fe7dac7

> Inspection records and compliance data for Fresenius Kabi Oncology Limited in Baddi. 6 FDA inspections on record (3 OAI), 2 Form 483s, last inspected October 10, 2023.

---

## Details

- Name: Fresenius Kabi Oncology Limited
- FEI Number: 3006210232
- Business Operations: FDF MANUFACTURE
- Address Line 1: Tehsil Nalagarh, Nalagarh Baddi Road
- City: Baddi
- Country Name: India
- Address: Tehsil Nalagarh, Nalagarh Baddi Road, Baddi, India
- Country: India

## Related Documents

- [483 - Fresenius Kabi Oncology Limited - 2023-10-10](https://www.keypedia.com/records/483/fresenius-kabi-oncology-limited/d19a7f12-f3d8-4588-ac33-b115b6673823) — source: FDA, date: October 10, 2023
- [FDA Inspection 1220476 - Fresenius Kabi Oncology Limited - 2023-10-10](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/dc8162a0-065c-401c-8acb-840e7383f7b6) — classification: Official Action Indicated (OAI), source: FDA, date: October 10, 2023
- [FDA Inspection 1010068 - Fresenius Kabi Oncology Limited - 2017-04-14](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/42903d1f-060a-4dcd-8951-8789e2815a3f) — classification: Official Action Indicated (OAI), source: FDA, date: April 14, 2017
- [FDA Inspection 927828 - Fresenius Kabi Oncology Limited - 2015-05-22](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/7201f1b5-aad4-4c49-9069-5a0fe9aa10f6) — classification: Official Action Indicated (OAI), source: FDA, date: May 22, 2015
- [FDA Inspection 800493 - Fresenius Kabi Oncology Limited - 2012-08-28](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/519f9a04-3931-4d10-bbe1-994e93613818) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 28, 2012
- FDA Inspection 636945 - Fresenius Kabi Oncology Limited - 2009-11-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2009
- [FDA Inspection 554278 - Fresenius Kabi Oncology Limited - 2008-11-20](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/8f62a1f2-bb9a-4ff4-bb2c-ac0a743a4e4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2008

## Related Companies

- [Windlas Healthcare Private Limited](https://www.keypedia.com/companies/windlas-healthcare-private-limited/1cf912ba-dbe9-4b74-ba3c-a7bc0bd8678f)
- [Pharmacyclics LLC](https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8)
- [Rajinder S. Shiwach, M.D.](https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec)
- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)
- [SC Johnson Professional USA, Inc.](https://www.keypedia.com/companies/sc-johnson-professional-usa-inc/e9b50d00-3095-4f01-9e05-4f21adc9812a)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Novo Nordisk A/S](https://www.keypedia.com/companies/novo-nordisk-as/c57b9a63-64b0-49c3-acb3-64866f304d30)
- [Dakhil, Dr Shaker](https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)

## Related Officers

- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)